Crystal Sumner - 05 Dec 2022 Form 4 Insider Report for Blend Labs, Inc. (BLND)

Role
Head of Legal, Compliance,Risk
Signature
/s/ Crystal Sumner
Issuer symbol
BLND
Transactions as of
05 Dec 2022
Net transactions value
-$25,724
Form type
4
Filing time
07 Dec 2022, 17:24:57 UTC
Previous filing
30 Nov 2022
Next filing
22 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLND Class A Common Stock Options Exercise $5,576 +6,409 +1.2% $0.8700 560,204 05 Dec 2022 Direct F1
transaction BLND Class A Common Stock Sale $16,726 -12,914 -2.3% $1.30 547,290 05 Dec 2022 Direct F1, F2, F3
transaction BLND Class A Common Stock Sale $14,573 -12,914 -2.4% $1.13 534,376 06 Dec 2022 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLND Stock Option (right to buy) Options Exercise $0 -6,409 -100% $0.000000* 0 05 Dec 2022 Class A Common Stock 6,409 $0.8700 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of these shares are represented by previously reported restricted stock units.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 This sale price represents the weighted average sale price of the shares sold ranging from $1.28 to $1.35 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 This sale price represents the weighted average sale price of the shares sold ranging from $1.11 to $1.155 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5 The shares subject to this option are fully vested and immediately exercisable.